They observed high TGFβ activity in cardiac fibroblasts and endothelial cells during the progress of heart failure, but ADAMTS2 overexpression (transcriptionally up-regulated by MYC) could reverse this, seemingly through the PI3K/AKT and mitogen-activated protein kinase (MAPK) pathways. This evidence concerns the gene ADAMTS2 and heart failure.